Amyris and ImmunityBio JV for next gen Covid-19 RNA vaccine
Upon completion of successful human trials and regulatory approval, the joint venture's goal is to start delivering the second-generation vaccine in 2022 as soon as is practically possible
Upon completion of successful human trials and regulatory approval, the joint venture's goal is to start delivering the second-generation vaccine in 2022 as soon as is practically possible
Healthy growth in domestic and emerging markets is expected to support revenue growth in the next few quarters
First emergency use authorization in the United States for a Covid-19 vaccine booster in adolescents 12 through 15 years of age
A toll-free helpline to be set up to help doctors and patients
The Health ID will allow users to connect with different healthcare providers and enable a consent-based sharing of personal health records
Oravax's oral VLP vaccine in development targets three SARS CoV-2 virus surface proteins, including proteins less susceptible to mutation, thus making the vaccine potentially more effective against current and future variants of the Covid-19 virus
The combination enhances Comar's customer value proposition by adding complementary closure and jar products and related precision mold-making expertise
The glucometer connects to one’s smartphone and provides actionable diagnostic information
Aim of the virtual conference is to facilitate Indian Pharma Industry adopt Green & Sustainable Chemistry as a tool to enhance Economic & Environmental Competitiveness
The contract award from the U.S. Department of Defense (DoD), on behalf of the U.S. Department of Health and Human Services, is part of an effort to ensure secure local supply and production capacity for critical products for pandemic preparedness
Subscribe To Our Newsletter & Stay Updated